Insulin Delivery Devices Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Insulin Delivery Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.0% during the forecast period.

    This report presents the market size and development trends by detailing the Insulin Delivery Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Insulin Delivery Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Insulin Delivery Devices industry and will help you to build a panoramic view of the industrial development.

    Insulin Delivery Devices Market, By Type:

    • Insulin Pens

    • Insulin Pumps

    • Insulin Syringes

    • Others

    Insulin Delivery Devices Market, By Application:

    • Patients/Homecare

    • Hospitals & Clinics

    Some of the leading players are as follows:

    • West Pharma

    • MannKind

    • Dance Biopharm

    • Tandem Diabetes Care

    • Debiotech

    • Copernicus

    • Medtronic

    • Owen Mumford

    • Animas

    • SOOIL

    • Insulet

    • Cellnovo

    • BD

    • Beta Bionics

    • Ypsomed

    • Roche

    • Sanofi

    • Eli Lilly

    • Novo Nordisk

    • Valeritas

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Insulin Delivery Devices Market: Technology Type Analysis

    • 4.1 Insulin Delivery Devices Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Insulin Delivery Devices Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Insulin Pens

      • 4.3.2 Insulin Pumps

      • 4.3.3 Insulin Syringes

      • 4.3.4 Others

    5 Insulin Delivery Devices Market: Product Analysis

    • 5.1 Insulin Delivery Devices Product Market Share Analysis, 2018 & 2026

    • 5.2 Insulin Delivery Devices Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Insulin Delivery Devices Market: Application Analysis

    • 6.1 Insulin Delivery Devices Application Market Share Analysis, 2018 & 2026

    • 6.2 Insulin Delivery Devices Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Patients/Homecare

      • 6.3.2 Hospitals & Clinics

    7 Insulin Delivery Devices Market: Regional Analysis

    • 7.1 Insulin Delivery Devices Regional Market Share Analysis, 2018 & 2026

    • 7.2 Insulin Delivery Devices Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 West Pharma

      • 9.1.1 West Pharma Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 MannKind

      • 9.2.1 MannKind Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Dance Biopharm

      • 9.3.1 Dance Biopharm Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Tandem Diabetes Care

      • 9.4.1 Tandem Diabetes Care Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Debiotech

      • 9.5.1 Debiotech Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Copernicus

      • 9.6.1 Copernicus Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Medtronic

      • 9.7.1 Medtronic Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Owen Mumford

      • 9.8.1 Owen Mumford Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Animas

      • 9.9.1 Animas Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 SOOIL

      • 9.10.1 SOOIL Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Insulet

      • 9.11.1 Insulet Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Cellnovo

      • 9.12.1 Cellnovo Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 BD

      • 9.13.1 BD Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Beta Bionics

      • 9.14.1 Beta Bionics Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Ypsomed

      • 9.15.1 Ypsomed Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Roche

      • 9.16.1 Roche Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Sanofi

      • 9.17.1 Sanofi Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 Eli Lilly

      • 9.18.1 Eli Lilly Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 Novo Nordisk

      • 9.19.1 Novo Nordisk Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

    • 9.20 Valeritas

      • 9.20.1 Valeritas Company overview

      • 9.20.2 Financial performance

      • 9.20.3 Product benchmarking

      • 9.20.4 Strategic initiatives

      • 9.20.5 SWOT analysis

     

    The List of Tables and Figures (Totals 83 Figures and 139 Tables)

    • Figure Insulin Pens Insulin Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Insulin Pumps Insulin Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Insulin Syringes Insulin Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Others Insulin Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Patients/Homecare market, 2015 - 2026 (USD Million)

    • Figure Hospitals & Clinics market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Insulin Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table North America Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table North America Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table North America Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Canada Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Canada Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Europe Insulin Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Europe Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Europe Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Europe Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Germany Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Germany Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table France Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table France Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Italy Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Italy Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Spain Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Spain Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Insulin Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table China Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table China Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Japan Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Japan Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table India Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table India Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Insulin Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table MEA Insulin Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table MEA Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table MEA Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table MEA Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Insulin Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Insulin Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Insulin Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table West Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table MannKind Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Dance Biopharm Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Tandem Diabetes Care Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Debiotech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Copernicus Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Medtronic Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Owen Mumford Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Animas Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table SOOIL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Insulet Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cellnovo Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BD Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Beta Bionics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ypsomed Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Valeritas Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.